Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Study unravels mechanisms by which saffron-based crocin prevents liver cancer

Study unravels mechanisms by which saffron-based crocin prevents liver cancer

YAP protein appears to play vital role in helping control inflammation inside the brain

YAP protein appears to play vital role in helping control inflammation inside the brain

SciClone plans to pursue development of SGX942 in the Greater China market

SciClone plans to pursue development of SGX942 in the Greater China market

Findings show promising evidence for creating broad-spectrum antiviral

Findings show promising evidence for creating broad-spectrum antiviral

RBHS Chancellor leads study to eliminate chronic viral hepatitis

RBHS Chancellor leads study to eliminate chronic viral hepatitis

Prophylaxis treatment can protect children who receive liver transplants from HBV-infected donors

Prophylaxis treatment can protect children who receive liver transplants from HBV-infected donors

SLU scientist awarded new $2.2 million NIH grant to develop cure for hepatitis B

SLU scientist awarded new $2.2 million NIH grant to develop cure for hepatitis B

New therapeutic target can prevent abnormal blood vessel growth that causes gastrointestinal bleeding

New therapeutic target can prevent abnormal blood vessel growth that causes gastrointestinal bleeding

Researchers discover 'triple attack' technique to target liver cancer tumors

Researchers discover 'triple attack' technique to target liver cancer tumors

Quest Diagnostics performs RNA testing on patient specimens to detect more cases of HCV

Quest Diagnostics performs RNA testing on patient specimens to detect more cases of HCV

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Researchers reveal new technique to grow human hepatocytes in the laboratory

Researchers reveal new technique to grow human hepatocytes in the laboratory

Liver's cannabinoid receptors could be targeted to combat liver cancer in some patients

Liver's cannabinoid receptors could be targeted to combat liver cancer in some patients

Fewer than 1 in 3 UK hospitals employ full-time doctors specialized in liver medicine

Fewer than 1 in 3 UK hospitals employ full-time doctors specialized in liver medicine

Crucial tumor-suppressing gene protects immune attack against lung cancer

Crucial tumor-suppressing gene protects immune attack against lung cancer

Nearly 50% of Medicaid patients infected with hepatitis C denied coverage for life-saving antiviral drugs

Nearly 50% of Medicaid patients infected with hepatitis C denied coverage for life-saving antiviral drugs

UC Irvine Health researchers develop one-step test to detect HCV infections

UC Irvine Health researchers develop one-step test to detect HCV infections

FixHepC Buyers Club exposes weakness in Australian healthcare, assists patients to import life saving medication

FixHepC Buyers Club exposes weakness in Australian healthcare, assists patients to import life saving medication

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

UT Southwestern's Helen H. Hobbs named recipient of Breakthrough Prize in Life Sciences

UT Southwestern's Helen H. Hobbs named recipient of Breakthrough Prize in Life Sciences

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.